Company Intelligence

Prenosis

Prenosis provides enterprise-grade artificial intelligence solutions, delivering specialized Prenosis Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Chicago, United States
Founded
2014
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026

Overview

What this company is, what it builds, and who it serves.

Prenosis is a Healthcare AI company based in Chicago, United States, founded in 2014.

Chicago digital health company whose FDA-authorized Sepsis ImmunoScore AI diagnostic integrates into acute-care EMR workflows.

Verified founder profile on Brel: Bobby Reddy Jr.

What it builds

Prenosis Platform

Why It Matters

Prenosis provides enterprise-grade artificial intelligence solutions, delivering specialized Prenosis Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

Founders

People linked to this company in the Brel founder graph.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Prenosis

Industry

Industries served

  • Digital Health

Capabilities

Prenosis's AI applies machine learning across combined biomarker and clinical feature sets trained on thousands of patients in its proprietary dataset —…

Features

Sepsis ImmunoScore AI software-as-a-medical-device analyzing 22 holistic patient parameters for sepsis diagnosis and 24-hour deterioration risk, built on the Immunix precision medicine…

Country

United States

Use cases

Official Resources

Official and developer links on file for this company.

Latest Developments

Verified developments and timeline notes on file.

  • April 10, 2024: Prenosis announced commercial distribution collaboration with Roche for Sepsis ImmunoScore. Latest
  • Company founded 2014 · founded Source
  • Leadership 2014 · leadership Source
  • Development 2024 · development Source

Partnerships

  • April 10, 2024: Prenosis announced commercial distribution collaboration with Roche for Sepsis ImmunoScore.

Frequently Asked Questions

What does Prenosis do?

Prenosis specializes in artificial intelligence, developing Prenosis Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is Prenosis based and when was it founded?

Prenosis is based in United States and was founded in 2014.

What are the main products offered by Prenosis?

The flagship platform from Prenosis is Prenosis Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Prenosis?

Prenosis primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.